Pediatric Drug Development: Challenges and Opportunities.
作者信息
Spadoni Cesare
机构信息
aPODD Foundation, London, UK and the Medicines for Children Research Network (MCRN) Hungary, Budapest, Hungary.
出版信息
Curr Ther Res Clin Exp. 2018 Dec 28;90:119-122. doi: 10.1016/j.curtheres.2018.12.001. eCollection 2019.
Abstract
摘要
相似文献
1
Pediatric Drug Development: Challenges and Opportunities.儿科药物研发：挑战与机遇
Curr Ther Res Clin Exp. 2018 Dec 28;90:119-122. doi: 10.1016/j.curtheres.2018.12.001. eCollection 2019.
2
Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation.儿科人群中医疗疗法的开发所面临的挑战与机遇以及外推的作用。
Clin Pharmacol Ther. 2018 Mar;103(3):419-433. doi: 10.1002/cpt.1000. Epub 2018 Jan 31.
3
Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.儿科患者中HIV药物研发的挑战与机遇
Paediatr Drugs. 2017 Apr;19(2):91-98. doi: 10.1007/s40272-016-0210-4.
4
Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology.开发儿科中枢神经系统疾病药物面临的挑战：聚焦于精神药理学。
Prog Neurobiol. 2017 May;152:38-57. doi: 10.1016/j.pneurobio.2016.05.003. Epub 2016 May 20.
5
Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.肯尼亚采用和常规使用早期预警指标监测儿童艾滋病毒耐药性面临的挑战与机遇。
BMC Pediatr. 2018 Jul 25;18(1):243. doi: 10.1186/s12887-018-1209-5.
6
Challenges and Opportunities for Continued Success and Growth of Pediatric Interventional Radiology: A Communiqué From the Society for Pediatric Interventional Radiology.儿科介入放射学持续成功与发展的挑战与机遇：来自儿科介入放射学会的公报。
AJR Am J Roentgenol. 2018 Oct;211(4):740-743. doi: 10.2214/AJR.18.19936. Epub 2018 Jul 31.
7
Pediatric laboratory medicine: current challenges and future opportunities.儿科检验医学：当前挑战与未来机遇
Am J Clin Pathol. 2002 May;117(5):683-90. doi: 10.1309/NYA1-V9KQ-NVF8-MA8M.
8
The pediatric studies initiative: after 15 years have we reached the limits of the law?儿科研究倡议：15 年后，我们是否已经触及法律的界限？
Clin Ther. 2014 Feb 1;36(2):156-62. doi: 10.1016/j.clinthera.2013.11.007.
9
Challenges and considerations for development of therapeutic proteins in pediatric patients.儿科患者治疗性蛋白质开发的挑战与考量
J Clin Pharmacol. 2015 Mar;55 Suppl 3:S103-15. doi: 10.1002/jcph.382.
10
Pediatric drug formulations: a review of challenges and progress.儿科药物制剂：挑战与进展综述
Pediatrics. 2014 Aug;134(2):361-72. doi: 10.1542/peds.2013-3225. Epub 2014 Jul 14.
引用本文的文献
1
Addressing the drug development challenge for rare pediatric diseases in Japan: a case study of isotretinoin.应对日本罕见儿科疾病的药物开发挑战：异维A酸案例研究
Invest New Drugs. 2025 Jul 22. doi: 10.1007/s10637-025-01566-z.
2
'Challenges in pediatric medicine access in Albania: insights from community Pharmacists'.阿尔巴尼亚儿科医疗服务获取面临的挑战：社区药剂师的见解
J Pharm Policy Pract. 2025 Jul 2;18(1):2521425. doi: 10.1080/20523211.2025.2521425. eCollection 2025.
3
Effects of the Paediatric Regulation funding on the development of off-patent medicines in children.儿科监管资金对儿童非专利药品开发的影响。
Front Med (Lausanne). 2025 Jan 30;11:1473862. doi: 10.3389/fmed.2024.1473862. eCollection 2024.
4
Nanomedicine Therapies for Pediatric Diseases.儿科疾病的纳米医学疗法。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1996. doi: 10.1002/wnan.1996.
5
Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders.下一代儿科护理：基于纳米技术和人工智能驱动的心血管、呼吸和胃肠道疾病解决方案。
World J Pediatr. 2025 Jan;21(1):8-28. doi: 10.1007/s12519-024-00834-x. Epub 2024 Aug 28.
6
Analysis of the first ten years of FDA's rare pediatric disease priority review voucher program: designations, diseases, and drug development.FDA 罕见儿科疾病优先审评券计划头十年分析：指定、疾病和药物研发。
Orphanet J Rare Dis. 2024 Feb 25;19(1):86. doi: 10.1186/s13023-024-03097-x.
7
Development of CAR T Cell Therapy in Children-A Comprehensive Overview.儿童嵌合抗原受体T细胞疗法的发展——全面概述
J Clin Med. 2022 Apr 12;11(8):2158. doi: 10.3390/jcm11082158.
8
Dosing Recommendations for Pediatric Patients With Renal Impairment.儿科肾功能损害患者的推荐剂量。
J Clin Pharmacol. 2020 Dec;60(12):1551-1560. doi: 10.1002/jcph.1676. Epub 2020 Jun 15.
9
TuberOus SClerosis Registry to Increase Disease Awareness: A Review on Alignment of Its Planning, Execution, and Publications With European Medicines Agency Guidelines.结节性硬化症登记处提高疾病认知度：对其规划、实施及出版物与欧洲药品管理局指南一致性的综述
Front Neurol. 2020 May 15;11:365. doi: 10.3389/fneur.2020.00365. eCollection 2020.
Zotero 插件